Traws Pharma, Inc. (TRAW) Free cash flow 2018–2024
Traws Pharma, Inc. (TRAW) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$20.8MFY2024 · since FY2018: -$20.9M → -$20.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$20.8M | +37.9% |
| FY2023 | -$33.4M | -86.3% |
| FY2022 | -$17.9M | — |
| FY2019 | -$23.1M | -10.6% |
| FY2018 | -$20.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More TRAW financial trends
TRAW RevenueTRAW Net incomeTRAW Net marginTRAW Gross profitTRAW Gross marginTRAW Operating incomeTRAW Operating marginTRAW Operating cash flowTRAW Capital expendituresTRAW Return on equityTRAW Stock buybacksTRAW Dividends paidTRAW Total assetsTRAW Total liabilitiesTRAW Shareholders’ equityTRAW overview →